Your browser doesn't support javascript.
loading
A novel digital tool for detection and monitoring of amyotrophic lateral sclerosis motor impairment and progression via keystroke dynamics.
Acien, Alejandro; Calcagno, Narghes; Burke, Katherine M; Mondesire-Crump, Ijah; Holmes, Ashley A; Mruthik, Sri; Goldy, Ben; Syrotenko, Janina E; Scheier, Zoe; Iyer, Amrita; Clark, Alison; Keegan, Mackenzie; Ushirogawa, Yoshiteru; Kato, Atsushi; Yasuda, Taku; Lahav, Amir; Iwasaki, Satoshi; Pascarella, Mark; Johnson, Stephen A; Arroyo-Gallego, Teresa; Berry, James D.
Afiliação
  • Acien A; Area 2 AI Corporation, 245 Main St, Cambridge, MA, 02142, USA.
  • Calcagno N; nQ Medical, Cambridge, MA, USA.
  • Burke KM; Department of Neurology, Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, MA, USA.
  • Mondesire-Crump I; Neurology Residency Program, University of Milan, Milan, Italy.
  • Holmes AA; Department of Neurology, Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, MA, USA.
  • Mruthik S; nQ Medical, Cambridge, MA, USA.
  • Goldy B; Simbec Orion, Wales, UK.
  • Syrotenko JE; nQ Medical, Cambridge, MA, USA.
  • Scheier Z; ProKidney Corporation, Winston-Salem, NC, USA.
  • Iyer A; nQ Medical, Cambridge, MA, USA.
  • Clark A; nQ Medical, Cambridge, MA, USA.
  • Keegan M; nQ Medical, Cambridge, MA, USA.
  • Ushirogawa Y; Department of Neurology, Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, MA, USA.
  • Kato A; Department of Neurology, Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, MA, USA.
  • Yasuda T; Department of Neurology, Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, MA, USA.
  • Lahav A; Department of Neurology, Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, MA, USA.
  • Iwasaki S; Mitsubishi Tanabe Pharma Corporation, Osaka, Osaka, Japan.
  • Pascarella M; Mitsubishi Tanabe Pharma Corporation, Osaka, Osaka, Japan.
  • Johnson SA; Mitsubishi Tanabe Pharma Corporation, Osaka, Osaka, Japan.
  • Arroyo-Gallego T; Mitsubishi Tanabe Pharma America, Inc, Jersey City, NJ, USA.
  • Berry JD; Mitsubishi Tanabe Pharma America, Inc, Jersey City, NJ, USA.
Sci Rep ; 14(1): 16851, 2024 Jul 22.
Article em En | MEDLINE | ID: mdl-39039102
ABSTRACT
Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative condition leading to progressive muscle weakness, atrophy, and ultimately death. Traditional ALS clinical evaluations often depend on subjective metrics, making accurate disease detection and monitoring disease trajectory challenging. To address these limitations, we developed the nQiALS toolkit, a machine learning-powered system that leverages smartphone typing dynamics to detect and track motor impairment in people with ALS. The study included 63 ALS patients and 30 age- and sex-matched healthy controls. We introduce the three core components of this toolkit the nQiALS-Detection, which differentiated ALS from healthy typing patterns with an AUC of 0.89; the nQiALS-Progression, which separated slow and fast progression at specific thresholds with AUCs ranging between 0.65 and 0.8; and the nQiALS-Fine Motor, which identified subtle progression in fine motor dysfunction, suggesting earlier prediction than the state-of-the-art assessment. Together, these tools represent an innovative approach to ALS assessment, offering a complementary, objective metric to traditional clinical methods and which may reshape our understanding and monitoring of ALS progression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progressão da Doença / Smartphone / Esclerose Lateral Amiotrófica Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progressão da Doença / Smartphone / Esclerose Lateral Amiotrófica Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article